Biosimilars Market Players:
- Biocon Limited
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amgen Inc.
- Novartis AG
- Intas Pharmaceuticals Ltd.
- BioXpress Therapeutics SA
- Genor Biopharma Co. Ltd
- Allergan plc (AbbVie Inc.)
- Coherus BioSciences, Inc.
- Pfizer Inc.
- Reliance Life Sciences Private Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of biosimilars is assessed at USD 41.34 billion.
The global biosimilars market size was valued at over USD 36.08 billion in 2025 and is expected to expand at a CAGR of around 16.2%, surpassing USD 161.93 billion revenue by 2035.
Europe is projected to account for the largest revenue share of the biosimilars market by 2035, owing to the presence of a strong healthcare network, increasing number of hospitals and diseases, rising awareness among healthcare providers, and surge in biosimilar prescribing generating high savings from competition.
Key players in the market include Weatherman, Upper Echelon Products LLC, FanHE Umbrellas, London Undercover Limited, Raintec Umbrellas, Shaoxing Shangyu Yuzi Outdoor Products Co., Ltd., Happy Umbrella Foundation, Citizen Watch Co., Ltd., Woodline Shade Solutions PTY Ltd, Uhlmann Sonnenschirme e.K., Fulton Umbrellas.
